Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ciclesonide Clinical Trial for COVID-19 Treatment

NCT04435795 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT04435795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ciclesonide Clinical Trial for COVID-19 Treatment
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 2/3
Overall status
Terminated
Start date
September 15, 2020
Completion date
July 8, 2021
Enrollment
215 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19